viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Azacitidine
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Amilix
Argentiina
Arquimes
Argentiina
Azacimyl
Tšiili
Azacitidina
Argentiina, Maroko, Tšiili
Azacitidine
Ameerika ühendriigid
Azacor
Maroko
Azadin
Türgi
Azamex
Argentiina
Azanova
Argentiina
Azateva
Argentiina
Azida
Türgi
Azitech
Argentiina
Iclacitidina
Maroko
Iterbil
Argentiina
Maturus
Argentiina
Mietozitidina
Argentiina, Maroko
Nimodac
Argentiina
Remitiva
Argentiina, Tšiili
Tazadir
Argentiina
Vidaza
Ameerika ühendriigid, Argentiina, Belgia, Hispaania, Island, Kanada, Kolumbia, Malaisia, Maroko, Mehhiko, Norra, Prantsusmaa, Rumeenia, Saksamaa, Suurbritannia, Sveits, Tšiili, Türgi, uus-Meremaa
Wunduza
Tšiili
Zacidonel
Mehhiko
Zylatadina
Argentiina
Viited : Azacitidine
tüüp
avaldamine
414
ajaleht
Den Hartigh J, Brandenburg HCR, Vermeij P.
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Am J Hosp Pharm 1989 ; 46: 2500-2505.
1039
ajaleht
Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.
Stability of azacitidine in infusion fluids.
Am J Hosp Pharm 1984 ; 41: 1156-1159.
3204
ajaleht
Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M.
Stability of Azacitidine Suspensions.
Ann Pharmacotherapy 2011 ;45, 4:546.
3236
Labor
Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
Celgene 2011
3246
plakat
Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M.
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
SFPO Congress Mandelieu, France 2011
3351
ajaleht
Walker S.E, Charbonneau L.F, Law S, Earle C.
Stability of Azacitidine in Sterile Water for Injection.
Can J Hosp Pharm 2012 ; 65, 5: 352-359
3534
ajaleht
Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Am J Health-Syst Pharm 2013 ; 70:2137-2142
3816
plakat
Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F.
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
SFPO Congress, Nantes, France 2015
3818
ajaleht
Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F.
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.
4227
plakat
Tyono I, Law S, Charbonneau L.F, Walker S.E.
Stability of Azacitidine Solutions In Sterile Water for Injection.
Prof Practice Conference - Canadian Society of PH 2019
4628
ajaleht
Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B.
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Pharmaceuticals 2021 ; 14, 943.
4697
ajaleht
Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B.
Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage.
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003
Mentions Légales